Strides Receives USFDA VAI Closure For Flagship Bengaluru Facility

Strides’ Bengaluru flagship facility received the USFDA’s Establishment Inspection Report, closing its May inspection after five Form 483 observations; the outcome was classified Voluntary Action Indicated. Context: resolves the previously pending regulatory outcome.